Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Smith

Showing results (171-180 of 319) with videos related to

Pageof 32
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2008
Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activityVera Hirsh, Pierre P Major, Allan Lipton, et al.
Future Oncology (London, England)|June 3, 2022
Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS trialMatthew R Smith, Maha Hussain, Fred Saad, et al.
Food and Nutrition Bulletin|August 3, 2018
Impact of Historical Changes in Coarse Cereals Consumption in India on Micronutrient Intake and Anemia PrevalenceRuth DeFries, Ashwini Chhatre, Kyle Frankel Davis, et al.
The Journal of Urology|August 21, 2010
Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancerMatthew R Smith, Ronald A Morton, K Gary Barnette, et al.
The Journal of Urology|December 14, 2012
Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancerMatthew R Smith, Ronald A Morton, K Gary Barnette, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 1, 2012
Intercurrent infection predicts mortality in patients with late hepatic artery thrombosis listed for liver retransplantationJoanna Agnes Leithead, Matthew R Smith, Luke B Materacki, et al.
European Urology Focus|February 27, 2026
ARAMON, a phase 2 open-label trial of darolutamide monotherapy in patients with biochemical recurrence or oligometastatic castration-sensitive prostate cancer after radical prostatectomy or primary radiotherapyAndrew L Laccetti, Matthew R Smith, Howard I Scher, et al.
Critical Care Medicine|January 10, 2025
Windows in the ICU and Postoperative Delirium: A Retrospective Cohort StudyDiana C Anderson, Paige E Warner, Matthew R Smith, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 28, 2025
Association of Anesthesia Type and Vasoconstrictor Use with Intranodal Lymphangiography Duration: A Multicenter Retrospective Cohort StudyBrian J Kinsman, Sara Smolinski-Zhao, Fran D Soljacic, et al.
Bioorganic & Medicinal Chemistry|July 25, 2008
Design, synthesis and biological evaluation of new tryptamine and tetrahydro-beta-carboline-based selective inhibitors of CDK4Paul R Jenkins, James Wilson, Daniel Emmerson, et al.
Pageof 32

Showing results (171-180 of 319) with videos related to

Sort By:
Pageof 32
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2008
Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activityVera Hirsh, Pierre P Major, Allan Lipton, et al.
Future Oncology (London, England)|June 3, 2022
Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS trialMatthew R Smith, Maha Hussain, Fred Saad, et al.
Food and Nutrition Bulletin|August 3, 2018
Impact of Historical Changes in Coarse Cereals Consumption in India on Micronutrient Intake and Anemia PrevalenceRuth DeFries, Ashwini Chhatre, Kyle Frankel Davis, et al.
The Journal of Urology|August 21, 2010
Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancerMatthew R Smith, Ronald A Morton, K Gary Barnette, et al.
The Journal of Urology|December 14, 2012
Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancerMatthew R Smith, Ronald A Morton, K Gary Barnette, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 1, 2012
Intercurrent infection predicts mortality in patients with late hepatic artery thrombosis listed for liver retransplantationJoanna Agnes Leithead, Matthew R Smith, Luke B Materacki, et al.
European Urology Focus|February 27, 2026
ARAMON, a phase 2 open-label trial of darolutamide monotherapy in patients with biochemical recurrence or oligometastatic castration-sensitive prostate cancer after radical prostatectomy or primary radiotherapyAndrew L Laccetti, Matthew R Smith, Howard I Scher, et al.
Critical Care Medicine|January 10, 2025
Windows in the ICU and Postoperative Delirium: A Retrospective Cohort StudyDiana C Anderson, Paige E Warner, Matthew R Smith, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 28, 2025
Association of Anesthesia Type and Vasoconstrictor Use with Intranodal Lymphangiography Duration: A Multicenter Retrospective Cohort StudyBrian J Kinsman, Sara Smolinski-Zhao, Fran D Soljacic, et al.
Bioorganic & Medicinal Chemistry|July 25, 2008
Design, synthesis and biological evaluation of new tryptamine and tetrahydro-beta-carboline-based selective inhibitors of CDK4Paul R Jenkins, James Wilson, Daniel Emmerson, et al.
Pageof 32